Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 1/20 | 0.47 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | REN | P00797 | 2/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 8/20 | 0.38 |
| ▸ | PGR | P06401 | 3/20 | 0.38 |
| ▸ | ATR | Q13535 | 1/20 | 0.38 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15712028 | 0.81 | PRKCI (0.50) | AXLNUDT1AHRRENKEAP1 | |
| SCHEMBL31492457 | 0.81 | AHR (0.60) | AHRRENKEAP1PDPK1NR3C1 | |
| SCHEMBL17123043 | 0.76 | MMP2 (0.46) | AXLNUDT1AHRRENKEAP1 | |
| SCHEMBL18000230 | 0.76 | PIK3CD (0.54) | AXLNUDT1AHRRENKEAP1 | |
| Quinoline SCHEMBL27719790 | 0.74 | ALDH1A1 (0.50) | AXLNUDT1AHRRENKEAP1 | |
| SCHEMBL30752381 | 0.74 | ADRA1A (0.43) | AXLNUDT1AHRRENKEAP1 | |
| SCHEMBL15617226 | 0.73 | PDE10A (0.42) | AXLNUDT1AHRRENKEAP1 | |
| SCHEMBL28980960 | 0.73 | IDO1 (0.49) | AHRRENKEAP1PDPK1 | |
| SCHEMBL12676642 | 0.73 | AHR (0.43) | AXLNUDT1AHRRENKEAP1 | |
| SCHEMBL30741488 | 0.73 | AHR (0.43) | AXLNUDT1AHRRENKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | AXL 1389/4885NUDT1 3382/4885AHR 4043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.